Category: HypertensionSyndicate content

Renal Denervation: Medtronic taking another shot at drug-resistant hypertension

February 20, 2015 by Mark Hollmer

Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hypertension: Stealthy Verve Medical raises $2m for RDN device

February 3, 2015 by Mark Hollmer

Verve Medical raises just less than $2 million in an equity offering for its renal denervation device.

Hypertension: Stealthy Verve Medical raises $2m for RDN device

Stealthy renal denervation startup Verve Medical raised close to $2 million, according to a regulatory filing, with funding likely slated to help support clinical trials.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: Rox Medical's Coupler hypertension stent fares well in pivotal trial

January 28, 2015 by Mark Hollmer

Rox Medical's stent-like Coupler implant, designed to treat resistant hypertension, fares well in a pivotal trial as the company gears up for a run at an investigational device exemption from the FDA.

Vascular Dynamics secures $17m Series B round

January 13, 2015 by Val Kennedy

Vascular Dynamics secures a $17 million Series B round to fund clinical trials for its device to treat drug-resistant hypertension.

Vascular Dynamics secures $17m Series B round

Vascular Dynamics said it secured $16.85 million in Series B financing to fund clinical trials for its device to treat drug-resistant hypertension.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Hypertension: CVRx wins FDA nod for Barostim neo legacy

December 17, 2014 by Val Kennedy

The FDA grants a humanitarian device exemption for CVRx's Barostim neo legacy device for treating drug-resistant hypertension.

Hypertension: CVRx wins FDA nod for Barostim neo legacy

CVRx said yesterday that it won a humanitarian device exemption from the FDA for its Barostim neo legacy device, to treat drug-resistant hypertension.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

December 10, 2014 by Brad Perriello

An analysis of Medtronic's failed Symplicity-3 renal denervation trial highlights several 'confounding' factors that may have contributed to a missed efficacy endpoint, suggesting a way forward for more RDN studies.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Vascular Dynamics raises $10m

November 7, 2014 by Val Kennedy

Vascular Dynamics reports raising $10 million out of a hoped-for $23 million funding round for its MobiusHD anti-hypertension implant.

Vascular Dynamics raises $10m

Vascular Dynamics said it raised nearly $10 million from a group of unnamed investors for the hypertension implant it's developing.

The Mountain View, Calif.-based startup reported raising $9.7 million in an offering of stock, warrants and other securities as part of a proposed $22.9 million funding round.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.